000 01783 a2200529 4500
005 20250517025359.0
264 0 _c20150623
008 201506s 0 0 eng d
022 _a1878-3686
024 7 _a10.1016/j.ccell.2015.03.004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZhu, Eric F
245 0 0 _aSynergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2.
_h[electronic resource]
260 _bCancer cell
_cApr 2015
300 _a489-501 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAdaptive Immunity
650 0 4 _aAnimals
650 0 4 _aCD8-Positive T-Lymphocytes
_xdrug effects
650 0 4 _aDrug Synergism
650 0 4 _aHalf-Life
650 0 4 _aImmunity, Innate
650 0 4 _aImmunotherapy
650 0 4 _aInterleukin-2
_xmetabolism
650 0 4 _aKiller Cells, Natural
_xdrug effects
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aNeoplasms
_ximmunology
700 1 _aGai, Shuning A
700 1 _aOpel, Cary F
700 1 _aKwan, Byron H
700 1 _aSurana, Rishi
700 1 _aMihm, Martin C
700 1 _aKauke, Monique J
700 1 _aMoynihan, Kelly D
700 1 _aAngelini, Alessandro
700 1 _aWilliams, Robert T
700 1 _aStephan, Matthias T
700 1 _aKim, Jacob S
700 1 _aYaffe, Michael B
700 1 _aIrvine, Darrell J
700 1 _aWeiner, Louis M
700 1 _aDranoff, Glenn
700 1 _aWittrup, K Dane
773 0 _tCancer cell
_gvol. 27
_gno. 4
_gp. 489-501
856 4 0 _uhttps://doi.org/10.1016/j.ccell.2015.03.004
_zAvailable from publisher's website
999 _c24803949
_d24803949